Australia markets closed

NVDA Jun 2021 570.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.06000.0000 (0.00%)
As of 2:31PM EDT. Market open.
Full screen
Previous close0.0600
Open0.0500
Bid0.0000
Ask0.0000
Strike570.00
Expiry date2021-06-18
Day's range0.0500 - 0.0800
Contract rangeN/A
Volume13
Open interest1.82k
  • TuSimple Stock: The Driverless Truck Stock That Counts NVIDIA and Cathie Wood as Investors
    Motley Fool

    TuSimple Stock: The Driverless Truck Stock That Counts NVIDIA and Cathie Wood as Investors

    The company has some impressive investors and partners. Tech giant NVIDIA (NASDAQ: NVDA) was an early investor and hot-stock picker Cathie Wood has been buying shares of the newly public company for two of her Ark Invest exchange-traded funds (ETFs). TuSimple, founded in 2015, is based in San Diego and also has U.S. locations in Tucson, Arizona, and Fort Worth, Texas.

  • Investing in the Intel Turnaround? Don't Be Too Quick to Draw Comparisons With AMD
    Motley Fool

    Investing in the Intel Turnaround? Don't Be Too Quick to Draw Comparisons With AMD

    The world's largest semiconductor company (as measured by revenue), Intel (NASDAQ: INTC), has not been having a good go of it as of late. The company has fallen behind technologically to leading chip fabrication behemoth Taiwan Semiconductor (NYSE: TSM), and myriad other chip designers like NVIDIA (NASDAQ: NVDA) have been scooping up sales from Intel's dominant PC and data center biz. Intel has a plan to invest heavily in its fabrication process and revamp its product designs, though, and some investors have drawn parallels between Intel now and where scrappy general purpose chip company AMD (NASDAQ: AMD) was in the years following the Great Recession of 2008-2009.

  • The Zacks Analyst Blog Highlights: NVIDIA, Target, Lam Research, Alphabet and Intuitive Surgical
    Zacks

    The Zacks Analyst Blog Highlights: NVIDIA, Target, Lam Research, Alphabet and Intuitive Surgical

    The Zacks Analyst Blog Highlights: NVIDIA, Target, Lam Research, Alphabet and Intuitive Surgical